Life Sciences: Cell/Gene Therapy

Precision Traceability From Donor to Patient

Cell and gene therapy represents the most complex manufacturing challenge in life sciences today. Answerthink® helps cell and gene therapy organizations build the SAP foundation to manage donor tracking, patient-specific manufacturing, quality compliance, and protected health data – before commercial scale makes getting it right even harder.

Setting the right foundation early

Cell and gene therapy companies are building something the life sciences industry has never built before: personalized, living medicines manufactured one patient at a time, or next-generation biologics requiring process precision that traditional pharmaceutical manufacturing was never designed to support.

Unlike traditional drug manufacturing, cell and gene therapy introduces a layer of complexity that touches every system in your organization: Patient identity must be maintained through every step of manufacturing, protected health information must be safeguarded across your entire operational infrastructure, and every batch (often a single dose for a single patient) must be traceable from collection through release with zero margin for error.

Most cell and gene therapy companies encounter these challenges while still in clinical development, before the full weight of commercial-scale compliance has arrived. Answerthink® works with cell and gene therapy organizations at the clinical and precommercial stage to implement SAP solutions that are built for the unique demands of this space, and ready to scale when the therapy is.

HIPAA

Because cell and gene therapy manufacturing is tied to individual patients, your operational systems handle protected health information – making the Health Insurance Portability and Accountability Act (HIPAA) compliance an enterprise resource planning (ERP) requirement, not just an information technology (IT) policy. Answerthink® configures SAP environments that maintain patient data security across manufacturing, quality and distribution workflows from day one.

Outcomes we deliver

Maintain unbroken chain of identity (COI) and chain of custody (COC) from donor collection through manufacturing, quality release, and patient delivery.

Manage patient-specific, make-to-order manufacturing workflows with full lot and batch traceability at the individual unit level.

Classify and track biological materials, cell types, and therapy variants within a single compliant system.

Orchestrate the end-to-end patient journey – aligning apheresis scheduling, manufacturing slots, and infusion site readiness through integration with specialized cell therapy orchestration platforms.

Protect patient data across all operational systems with HIPAA-compliant SAP configuration and role-based access controls.

Build GxP-compliant quality management processes – deviation handling, corrective and preventative actions (CAPAs), and change controls – designed for the pace and precision of cell and gene therapy manufacturing.

Establish a scalable SAP foundation during clinical development that supports commercial manufacturing without requiring a system rebuild at launch.

Satisfy CBER regulatory requirements with validated processes, electronic records and audit-ready documentation.

Validation-ready implementation

Answerthink® delivers every SAP implementation with a structured validation approach built for regulated environments – following GAMP 5 principles and the FDA’s risk-based Computer Software Assurance (CSA) direction.

Our process includes:

We work with a leading life sciences validation specialist to support clients through both initial validation and long-term compliance continuity.

SAP capabilities for cell and gene therapy

Answerthink® supports SAP Cloud ERP deployment models, helping regulated clients choose the architecture that fits their compliance posture, IT strategy and timeline. SAP’s platform addresses the intersection of patient identity, biologics manufacturing complexity, and regulated quality management that defines cell and gene therapy operations:

  • Make-to-order manufacturing configuration that ties every production order to a specific donor or patient record – maintaining COI across the full vein-to-vein workflow, with COC documented at every material transfer point through electronic signature controls
  • Donor and material classification frameworks that support biological material tracking, donor screening status and lot-level traceability from collection through release
  • HIPAA-aligned data architecture within SAP S/4HANA – securing protected health information across manufacturing, quality, and logistics workflows with role-based access and audit trails
  • Integrated quality management for GxP environments, covering batch records, deviations, CAPAs, change controls, and electronic signatures meeting 21 CFR Part 11 requirements
  • Support data integrity requirements aligned with ALCOA+ principles (attributable, legible, contemporaneous, original, accurate, complete, consistent, enduring, available) – a high-priority focus for FDA and global regulatory agencies
  • Scalable process and documentation frameworks designed to transition from clinical-scale batch manufacturing to commercial production without losing regulatory continuity
  • SAP Extended Warehouse Management (EWM) configured for cryogenic and ultra-cold storage – with location-level traceability for temperature-sensitive materials and integration with specialty cold-chain courier networks from manufacturing through patient delivery
  • SAP Intelligent Clinical Supply Management – connecting clinical supply planning, demand forecasting, manufacturing, and distribution of investigational materials across trial sites
  • Integration with existing technology platforms – including MES, and LIMS systems – ensuring compliant data continuity across your full technology stack rather than replacing the tools you already run

Life Sciences Insights and Resources

Plant to Patient Webcast Series Session 1 of 3: From Forecast to Field – The Rise of Agentic AI in MedTech

Plant to Patient Webcast Series Session 1 of 3: From Forecast to Field – The Rise of Agentic AI in MedTech

Where’s your inventory? Your systems may know, but your field team isn’t so sure. When…

The Four AI Agents Fast-Growth Medtech Companies Should Deploy First

The Four AI Agents Fast-Growth Medtech Companies Should Deploy First

5 Min Read

Artificial intelligence (AI) is starting to move from promise to workflow. IBM reports that 62%…

professional business woman with laptop

The Discipline of Doing Less

4 Min Read

For midmarket companies, enterprise resource planning (ERP) transformation carries a reputation for complexity, cost overruns,…

How to Overcome 6 ERP Challenges Slowing Biopharma Growth

How to Overcome 6 ERP Challenges Slowing Biopharma Growth

A practical guide to scaling operations, strengthening compliance, and accelerating growth with modern cloud ERP…

Building the next generation of medicine?
Build the right foundation first.

Answerthink® works with cell and gene therapy organizations at the clinical
and precommercial stage to implement SAP solutions that match the complexity
of what you’re building – and scale with you when it’s time to go commercial.